The p53/mouse double minute 2 homolog complex deregulation in merlin-deficient tumours
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The p53/mouse double minute 2 homolog complex deregulation in merlin-deficient tumours
Authors
Keywords
-
Journal
Molecular Oncology
Volume 9, Issue 1, Pages 236-248
Publisher
Wiley
Online
2014-08-27
DOI
10.1016/j.molonc.2014.08.005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Merlin-Deficient Human Tumors Show Loss of Contact Inhibition and Activation of Wnt/β-Catenin Signaling Linked to the PDGFR/Src and Rac/PAK Pathways
- (2015) Lu Zhou et al. NEOPLASIA
- Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival
- (2013) S Ammoun et al. ONCOGENE
- The p53 mRNA-Mdm2 Interaction Controls Mdm2 Nuclear Trafficking and Is Required for p53 Activation following DNA Damage
- (2012) Madhavsai Gajjar et al. CANCER CELL
- The rebel angel: mutant p53 as the driving oncogene in breast cancer
- (2012) D. Walerych et al. CARCINOGENESIS
- Human oncoprotein MDM2 activates the Akt signaling pathway through an interaction with the repressor element-1 silencing transcription factor conferring a survival advantage to cancer cells
- (2012) S Singh et al. CELL DEATH AND DIFFERENTIATION
- Molecular Pathways: Targeting Mdm2 and Mdm4 in Cancer Therapy
- (2012) Q. Li et al. CLINICAL CANCER RESEARCH
- The role of insulin-like growth factors signaling in merlin-deficient human schwannomas
- (2012) Sylwia Ammoun et al. GLIA
- Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2
- (2011) Jaishri O. Blakeley et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Loss of Tumor Suppressor Merlin in Advanced Breast Cancer Is due to Post-translational Regulation
- (2011) K. Adam Morrow et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- p53 and its mutants in tumor cell migration and invasion
- (2011) Patricia A. J. Muller et al. JOURNAL OF CELL BIOLOGY
- Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2
- (2011) S. Ammoun et al. NEURO-ONCOLOGY
- Merlin/NF2 Suppresses Tumorigenesis by Inhibiting the E3 Ubiquitin Ligase CRL4DCAF1 in the Nucleus
- (2010) Wei Li et al. CELL
- Moesin–ezrin–radixin-like protein (merlin) mediates protein interacting with the carboxyl terminus-1 (PICT-1)-induced growth inhibition of glioblastoma cells in the nucleus
- (2010) Hongbo Chen et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma
- (2010) S. Ammoun et al. NEURO-ONCOLOGY
- K-Ras4B phosphorylation at Ser181 is inhibited by calmodulin and modulates K-Ras activity and function
- (2010) B Alvarez-Moya et al. ONCOGENE
- TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
- (2009) M. Olivier et al. Cold Spring Harbor Perspectives in Biology
- Dissecting and Targeting the Growth Factor-Dependent and Growth Factor-Independent Extracellular Signal-Regulated Kinase Pathway in Human Schwannoma
- (2008) S. Ammoun et al. CANCER RESEARCH
- Nuclear FAK Promotes Cell Proliferation and Survival through FERM-Enhanced p53 Degradation
- (2008) Ssang-Taek Lim et al. MOLECULAR CELL
- Time-course Expression of DNA Repair-related Genes in Hepatocytes of Zebrafish (Danio rerio) After UV-B Exposure
- (2008) Juliana Z. Sandrini et al. PHOTOCHEMISTRY AND PHOTOBIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started